Characterization of the radiation field surrounding the Leksell Gamma Knife® and shielding applications.

The aim of this study is to improve the characterization and modeling of the radiation field surrounding the Leksell Gamma Knife®-Perfexion. The improved characterization of the radiation field enables more accurate shielding calculations to be performed for the areas adjacent to the treatment room. With the aid of a high-purity germanium detector and a satellite dose rate meter, γ-ray spectra and ambient dose equivalent H*(10) data were acquired at various locations in the field of a Leksell Gamma Knife unit in a treatment room at Karolinska University Hospital, Sweden.

On the stability of Leksell Vantage stereotactic head frame fixation in Gamma Knife radiosurgery: a study based on cone-beam computed tomography imaging and the High Definition Motion Management system.

Objective: The authors' objective was to investigate the stability of the newly introduced Vantage stereotactic frame fixation in single-fraction Gamma Knife radiosurgery.

Methods: A total of 255 patients were included in this work and treated with the Vantage frame and Leksell Gamma Knife (LGK) Icon equipped with cone-beam computed tomography (CBCT) imaging. After the frame was mounted on the patient's head, a CT scan was acquired.

Experimental investigation of TRS-483 reference dosimetry correction factors for Leksell Gamma Knife® Icon™ beams.

Purpose: Radiosurgery using the Leksell Gamma Knife® (LGK) Icon™ is an established technique used for treating intracranial lesions. The largest beam field size the LGK Icon can produce is a 16 mm diameter sphere. Despite this, reference dosimetry on the LGK Icon is typically performed using ionization chambers calibrated in 10 × 10 cm fields.

Metastatic renal cell carcinoma to the brain: optimizing patient selection for gamma knife radiosurgery.

Introduction: The effects of single-fraction gamma knife radiosurgery (sf-GKRS) on patients with renal cell carcinoma (RCC) brain metastases (BM) in the era of targeted agents (TA) and immune checkpoint inhibitors (ICI) are insufficiently studied.

Methods And Materials: Clear cell metastatic RCC patients treated with sf-GKRS due to BM in 2005-2014 at three European centres were retrospectively analysed (n = 43). Median follow-up was 56 months.

Integrating navigated transcranial magnetic stimulation motor mapping in hypofractionated and single-dose gamma knife radiosurgery: A two-patient case series and a review of literature.

Background: The aim of the study was to demonstrate the feasibility of integrating navigated transcranial magnetic stimulation (nTMS) in preoperative gamma knife radiosurgery (GKRS) planning of motor eloquent brain tumors.

Case Description: The first case was a 53-year-old female patient with metastatic breast cancer who developed focal epileptic seizures and weakness of the left hand. The magnetic resonance imaging (MRI) scan demonstrated a 30 mm metastasis neighboring the right precentral gyrus and central sulcus.